MicroPort Scientific Corp (MCRPF)
0.93
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
MicroPort Scientific Shareholders Equity (Quarterly): 757.82M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 757.82M |
| June 30, 2023 | 960.20M |
| June 30, 2023 | 960.20M |
| December 31, 2022 | 1.135B |
| June 30, 2022 | 1.235B |
| June 30, 2022 | 1.235B |
| December 31, 2021 | 1.491B |
| June 30, 2021 | 1.472B |
| June 30, 2021 | 1.472B |
| December 31, 2020 | 1.128B |
| June 30, 2020 | 629.18M |
| June 30, 2020 | 629.18M |
| December 31, 2019 | 519.02M |
| June 30, 2019 | 498.35M |
| June 30, 2019 | 498.35M |
| December 31, 2018 | 442.80M |
| June 30, 2018 | 408.59M |
| June 30, 2018 | 408.59M |
| December 31, 2017 | 401.60M |
| June 30, 2017 | 394.62M |
| Date | Value |
|---|---|
| June 30, 2017 | 394.62M |
| December 31, 2016 | 332.91M |
| June 30, 2016 | 334.76M |
| June 30, 2016 | 334.76M |
| December 31, 2015 | 312.52M |
| June 30, 2015 | 338.67M |
| June 30, 2015 | 338.67M |
| December 31, 2014 | 342.25M |
| June 30, 2014 | 386.54M |
| June 30, 2014 | 386.54M |
| December 31, 2013 | 390.43M |
| June 30, 2013 | 375.95M |
| June 30, 2013 | 375.95M |
| December 31, 2012 | 369.08M |
| June 30, 2012 | 354.36M |
| December 31, 2011 | 336.54M |
| June 30, 2011 | 325.10M |
| December 31, 2010 | 297.12M |
| June 30, 2010 | 79.82M |
| December 31, 2009 | 56.78M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
498.35M
Minimum
Jun 2019
1.491B
Maximum
Dec 2021
974.69M
Average
960.20M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 8.709B |
| CASI Pharmaceuticals Inc | 24.16M |
| Zai Lab Ltd | 762.17M |
| Gracell Biotechnologies Inc (DELISTED) | 222.18M |
| Adagene Inc | 70.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.932B |
| Total Liabilities (Quarterly) | 2.529B |
| Debt to Equity Ratio | 2.067 |
| Current Ratio | 1.582 |
| Net Debt Paydown Yield | -8.53% |